
Bioorganic and Medicinal Chemistry Letters p. 1867 - 1872 (1998)
Update date:2022-09-26
Topics:
Hulme, Christopher
Moriarty, Kevin
Miller, Bruce
Mathew, Rose
Ramanjulu, Mercy
Cox, Paul
Souness, John
Page, Ken M.
Uhl, Joanne
Travis, Jeffrey
Huang, Fu-Chih
Labaudiniere, Richard
Djuric, Stevan W.
This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram- like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-α levels in LPS challenged mice (mouse endotoxemia model) are also reported.
View MoreContact:
Address:308# dongwu avenue dongxihu district wuhan city
Hangzhou Bayee Chemical Co.,Ltd.
Contact:+86-571-86990109
Address:No.380, Jiangnan Auenue, Binjiang District, Hangzhou, China
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY
Contact:0086-0757-85609331
Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Contact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
Doi:10.1016/0584-8539(96)01680-7
(1996)Doi:10.1002/ardp.19973301205
(1997)Doi:10.3390/ijms20215481
(2019)Doi:10.1007/BF02253171
(1997)Doi:10.1039/DT9920002651
(1992)Doi:10.1055/s-1995-3887
(1995)